November 30, 2021
AmMax Bio Hosting Key Opinion Leader Webinar on AMB-05X for the...
REDWOOD CITY, Calif. Nov 30, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biotech company developing ...
May 26, 2021
AmMax Bio Announces First Patient Enrolled in Phase 2 Trial of AMB-05X...
RREDWOOD CITY, Calif. May 26, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...
February 16, 2021
AmMax Bio to Participate in the 41st Annual Cowen Health Care Conference
REDWOOD CITY, Calif. February 16, 2021 — AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...
October 20, 2021
AmMax Bio Announces Positive Interim Phase 2 Results of AMB-05X...
RREDWOOD CITY, Calif. October 20, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biotech company developing ...
April 29, 2021
AmMax Bio to Present at the BofA Securities 2021 Virtual Healthcare...
RREDWOOD CITY, Calif. Apr. 29, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...
March 30, 2020
LifeMax Launches AmMax Bio Following The License Of Worldwide Rights...
Redwood City, California – (Business Wire) – March 30, 2020 – LifeMax Laboratories, Inc. (“LifeMax”), a private company ...
July 14, 2021
AmMax Bio to Present at the 2nd Annual LifeSci Partners Private...
RREDWOOD CITY, Calif. July 14, 2021 —AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...
March 2, 2021
AmMax Bio Announces the Appointment of Biotechnology Executive...
REDWOOD CITY, Calif. March 2, 2021 — AmMax Bio, Inc. (“AmMax”), a private clinical-stage biopharmaceutical company ...